LES Response to RFC on USPTO Initiatives on Robustness and Reliability of Patent Rights
On January 31, 2023, LES submitted comments in Response [...]
LES Response on Patent Eligibility Restoration Act of 2022
LES USA & Canada Supports Patent Eligibility Restoration Act [...]
“Startup Central” at the LES 2022 Annual Meeting
The San Francisco Bay Area, home to Silicon Valley, [...]
LES Explains Flaws in Letter from Lawmakers to HHS Secretary Becerra Regarding Drug Price Controls
LES USA & Canada explains in a letter to [...]
LES Response on White House Announcement to Withdraw All Standard-Essential Patent Policy
The Licensing Executive Society (LES) USA & Canada Welcomes [...]
Now Available: 2021 Global “Life Sciences” Royalty Rates and Deal Terms Survey
LES membership carries with it many great benefits. From [...]
Calling All Innovators: The LES 2022 Annual Meeting Is Coming to San Francisco!
We will all be gathering in San Francisco this [...]
LES Perspective: Maintaining the Balance Between Innovators and Implementers
Earlier this year, I authored an article in Viewpoints [...]
Raising the Standard with LES
LES is proud of the many contributions our members [...]